Name: Welcome to Primary Health Care worker Training in Leprosy Module 2 'Compliant Treatment with MDT'
Uploaded: 2022-11-20
Duration: 4 min 48 s
Description: Welcome to Primary Health Care worker Training in Leprosy Module 2 ‘Compliant Treatment with MDT’.

Welcome to Primary Health Care worker Training in Leprosy Module 2 ‘Compliant Treatment with MDT’. 

Scene 1

Welcome to  Primary Health Care worker Training in Leprosy Module 2 ‘Compliant Treatment with MDT’

In the second module we will learn about the importance of early and compliant treatment of leprosy and how it can be ensured among those who have been started on treatment. 

Scene 2

In the second module we will learn about the  importance of early and compliant treatment of leprosy and how it can be ensured among those who have been started on treatment

The learning objectives of Module 2 ‘Compliant Treatment with MDT’ are At the end of the module the learner will be able to 1) Outline the importance of early, regular and complete treatment of leprosy 2) List the major groups of leprosy with their clinical features. 

Scene 3

The learning objectives of Module 2  ‘Compliant Treatment with MDT’ are At the end of the module the learner will be able to  1) Outline the importance of early, regular and       complete treatment of leprosy  2) List the major groups of leprosy with their clinical      features

3) Name the medicines used in the treatment of leprosy and outline the treatment regimen for each group of leprosy 4) Know the side effects of medicines and how to advise the patient in case of side effects 5) List the criteria for completion of MDT course. 

Scene 4

3) Name the medicines used in the treatment of       leprosy and outline the treatment regimen for each       group  of leprosy 4) Know the side effects of medicines and how to      advise the patient in case of side effects 5) List the criteria for completion of MDT course

6) Know methods to check for regularity of treatment and its completion 7) Define a defaulter and know now to trace and put him back on MDT. 

Scene 5

6) Know methods to check for regularity of       treatment and its completion  7) Define a defaulter and know now to trace and       put him back on MDT

Learning Objective 1 “Outline the importance of early, regular and complete treatment of leprosy” In the first learning objective of this module, - we will focus on knowing the importance of regular and complete treatment of leprosy. 

Scene 6

Learning Objective 1  “Outline the importance of early, regular and    complete treatment of leprosy”  In the  first learning objective  of this module, - we will focus on knowing the  importance of regular and complete treatment of leprosy

There are four reasons for early, regular and complete treatment of leprosy 1) To cure leprosy – medicines will get rid of all the bacilli of M Leprae and provide a cure from the disease 2) Delay in treatment of leprosy can lead to development of nerve damage and its consequences like deformities of hands, feet and eyes. 

Scene 7

There are four reasons for early, regular and complete treatment of leprosy 1) To cure leprosy – medicines will get rid of all the bacilli of M       Leprae and provide a cure from the disease 2) Delay in treatment of leprosy can lead to development of       nerve damage and its consequences like deformities of       hands, feet and eyes

3) If MDT is not taken regularly and is stopped or taken with gaps drug resistance to anti leprosy drugs will develop and treatment will be can ineffective against leprosy bacilli 4) Regular MDT will break transmission of leprosy by killing all the bacilli. This prevents shedding of bacilli into environment thus breaking transmission of leprosy. 

Scene 8

3) If MDT is not taken regularly and is stopped or taken with       gaps drug resistance to anti leprosy drugs will develop and       treatment will be can ineffective against leprosy bacilli   4) Regular MDT will break transmission of leprosy by killing all       the bacilli. This prevents shedding of bacilli into       environment thus breaking transmission of leprosy

Learning Objective 2 ‘List the major groups of leprosy with their clinical features’ In the second learning objective of this Module, we will learn about the two major groups of leprosy with their clinical features. 

Scene 9

Learning Objective 2  ‘List the major groups of leprosy with their clinical   features’  In the  second learning objective  of this Module, we will learn about the two major groups of leprosy with their clinical features

For the purpose of treatment leprosy is classified into two groups by World Health Organization (WHO) 1) Pauci-Bacillary (PB) 2) Multi-Bacillary (MB) Pauci-Bacillary (PB) Leprosy cases have - Five or less skin patches or - Only one nerve enlargement with or without five or less skin patches Multi- Bacillary Leprosy cases have - Six or more skin patches or - More than one nerve enlargement irrespective of number of skin patches. 

Scene 10

For the purpose of treatment leprosy is classified into two groups by World Health Organization (WHO)  1) Pauci-Bacillary (PB) 2) Multi-Bacillary (MB) Pauci-Bacillary (PB) Leprosy cases have - Five or less skin patches or                      - Only one nerve enlargement with or     without five or less skin patches  Multi- Bacillary Leprosy cases have  - Six or more skin patches or                     - More than one nerve enlargement irrespective of    number of skin patches

Learning Objective 3 ‘Name the medicines used in the treatment of leprosy and outline treatment regimen for each group of leprosy In the third learning objective of this module, we will name the medicines used in leprosy and the outline treatment regimen used for each group of leprosy. 

Scene 11

Learning Objective 3 ‘Name the medicines used in the treatment of  leprosy and outline treatment regimen for each group   of leprosy In the  third learning objective  of this module, we will name the medicines used in leprosy and the outline treatment regimen used for each group of leprosy

Medicines used in Leprosy are 1) Rifampicin 2) Clofazimine 3) Dapsone (DDS) These medicines are used in combination as Multi Drug Therapy (MDT). 

Scene 12

Medicines used in Leprosy are 1) Rifampicin 2) Clofazimine 3) Dapsone (DDS)  These medicines are used in combination as Multi Drug Therapy (MDT)

Treatment Regimen for leprosy WHO - Paucibacillary MDT – Adult Regimen 1) Rifampicin – 600 mg - once a month 2) DDS – 100 mg - once a day These two drugs are given for six months in paucibacillary leprosy WHO - Multibacillary MDT – Adult Regimen 1) Rifampicin – 600 mg – once a month 2) Clofazimine - 300 mg – once a month 50 mg – once a day 3) DDS – 100 mg once a day These three drugs are given for twelve months in multibacillary leprosy. 

Scene 13

Treatment Regimen for leprosy WHO - Paucibacillary MDT – Adult Regimen 1) Rifampicin – 600 mg - once a month  2) DDS            – 100 mg - once a day  These two drugs are given for  six months  in paucibacillary leprosy  WHO - Multibacillary MDT – Adult Regimen  1) Rifampicin –   600 mg – once a month  2) Clofazimine  - 300 mg – once a month                                 50 mg – once a day  3) DDS – 100 mg once a day  These three drugs are given for  twelve months  in multibacillary leprosy

Paucibacillary MDT – Child Regimen Age 10-14 1) Rifampicin – 450 mg – once a month 2) DDS – 50 mg - once a day These two drugs are given for six months in paucibacillary leprosy Age - less than 10 years Regimen remains as above, but dosages of medicines will have to be calculated according to body weight. 

Scene 14

Paucibacillary MDT – Child Regimen Age 10-14 1) Rifampicin – 450 mg – once a month  2) DDS             –   50 mg - once a day  These two drugs are given for  six months  in paucibacillary leprosy  Age - less than 10 years Regimen remains as above, but dosages of medicines will have to be calculated according to body weight

Multibacillary MDT– Child Regimen Age 10-14 1) Rifampicin – 450 mg – once a month 2) Clofazamine - 150 mg – once a month 50 mg – alternate days 2) DDS – 50 mg - once a day These three drugs are given for twelve months in multibacillary leprosy Age - less than 10 years Regimen remains as above, but dosages of medicines will have to be according to body weight. 

Scene 15

Multibacillary MDT– Child Regimen Age 10-14 1) Rifampicin    – 450 mg – once a month  2) Clofazamine  - 150 mg – once a month                                  50 mg – alternate days  2) DDS                –   50 mg -  once a day  These three drugs are given for  twelve months  in multibacillary leprosy  Age - less than 10 years Regimen remains as above, but dosages of medicines will have to be according to body weight

MDT Blister packs. Four types of blister packs are provided by WHO free of cost On the left side are the Adult packages On the right side are the Child packages Details of how to take it are also explained in this slide. 

Scene 16

Four  types of blister packs are    provided by WHO free of cost On the left side are the Adult packages  On the right side are the Child packages  Details of how to take it are also explained in this slide

Learning Objective 4 ‘Know the side effects of medicines and how to advise the patient in case of side effects’ In this learning objective we will learn about major side effects of medicines in MDT. 

Scene 17

Learning Objective 4 ‘Know the side effects of medicines and how to   advise the patient in case of side effects’ In this learning objective we will learn about major side effects of medicines in MDT

Side Effects of Medicines in MDT Rifampicin Mild - Reddish discoloration of urine, saliva or sweat – Reassure patient - Flu like symptoms – Symptomatic treatment Serious - Vomiting – Jaundice – Stop Rifampicin and Refer - Skin rash or allergy – Stop Rifampicin and Refer. 

Scene 18

Side Effects of Medicines in MDT Rifampicin Mild -  Reddish discoloration of urine, saliva or     sweat – Reassure patient  -  Flu like symptoms – Symptomatic treatment Serious  -  Vomiting – Jaundice – Stop Rifampicin and Refer -  Skin rash or allergy – Stop Rifampicin and Refer

Clofazamine - Brownish red discoloration of skin, urine, body fluids - Dryness of skin or eyes –Oil to skin and eye drops Dapsone - Paleness, tiredness or swelling of feet – Anemia – Deworm and Iron supplements Serious - Skin reaction – scaling – Stop Dapsone and Refer - Jaundice – Stop Dapsone and Refer. 

Scene 19

Clofazamine  - Brownish red discoloration of skin, urine, body    fluids - Dryness of skin or eyes –Oil to skin and eye drops  Dapsone - Paleness, tiredness or swelling of feet – Anemia –    Deworm and Iron supplements  Serious - Skin reaction – scaling – Stop Dapsone and Refer - Jaundice – Stop Dapsone and Refer

Learning Objective 5 ‘List the criteria for completion of MDT course’ In this learning objective we will list the criteria for completion of MDT course. 

Scene 20

Learning Objective 5 ‘List the criteria for completion of MDT course’  In this learning objective we will list the criteria for completion of MDT course

Criteria for completion of either PB or MB MDT are very important a) in determining the end of treatment for a person with leprosy b) in calculating treatment compliance rates in a leprosy program.. 

Scene 21

Criteria for completion of either PB or MB MDT are very important  a) in determining the end of treatment for a person      with leprosy   b) in calculating treatment compliance rates      in a leprosy program.